← FDA DRUG APPROVALS

FDA ANDA · ANDA077730

PRAVASTATIN SODIUM

Sponsor: PLIVA HRVATSKA DOO

APPLICATION
ANDA077730
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued, None (Tentative Approval)

Products

PRAVASTATIN SODIUMDiscontinued
PRAVASTATIN SODIUM 20MG · TABLET · ORAL
PRAVASTATIN SODIUMDiscontinued
PRAVASTATIN SODIUM 40MG · TABLET · ORAL
PRAVASTATIN SODIUMDiscontinued
PRAVASTATIN SODIUM 30MG · TABLET · ORAL
PRAVASTATIN SODIUMDiscontinued
PRAVASTATIN SODIUM 10MG · TABLET · ORAL
PRAVASTATIN SODIUMNone (Tentative Approval)
PRAVASTATIN SODIUM 80MG · TABLET · ORAL

Approval history

2006-11-21OriginalTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →